Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies
Ageing Research Reviews · 2023-03 · 85 · 101840
DOI: 10.1016/j.arr.2022.101840 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2023-03. Verfasst von Mir Hilal Ahmad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Neurobiology, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India; Genome Biology Lab,…. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 134-mal zitiert (Crossref) und nennt 255 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, ICMR, Ministry of Science and Technology.
Themen: Depression
Abstract (Originalsprache)
Parkinson's disease (PD) is characterized mainly by motor dysfunctions due to the progressive loss of dopaminergic neurons. However, PD patients experience a multitude of debilitating non-motor symptoms, including depression, which may have deleteriously detrimental effects on life. Depression is multifactorial and exhibits a bimodal progression in PD, but its underlying molecular mechanisms are poorly understood. Studies demonstrating the pathophysiology of depression in PD and the specific treatment strategies for depression-like symptoms in PD patients are largely lacking, often underrated, under-recognized and, consequently, inadequately/under-treated. Nevertheless, reports suggest that the incidence of depression is approximately 20-30% of PD patients and may precede the onset of motor symptoms. Diagnosing depression in PD becomes difficult due to the clinical overlap in symptomatology between the two diseases, and the nigrostriatal dysfunction alone is insufficient to explain depressive symptoms in PD. Therefore, the current study provides an overview of the molecular mechanisms underlying the development of depression in PD and new insights into developing current antidepressant strategies to treat depression in PD. This review will identify and understand the molecular pathological mechanisms of depression in PD that will fundamentally help tailoring therapeutic interventions for depressive symptoms in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Cellular and Molecular Neurobiology, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India; Genome Biology Lab, Department of Biosciences, Jamia Millia Islamia, New Delhi 110025, In…
- Genome Biology Lab, Department of Biosciences, Jamia Millia Islamia, New Delhi 110025, India.
- Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
- Laboratory of Cellular and Molecular Neurobiology, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India. Electronic address: acmondal@mail.jnu.ac.in.
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
- ICMR
- Ministry of Science and Technology
Zitieren
APA
Ahmad, M. H., Rizvi, M. A., Ali, M., & Mondal, A. C. (2023). Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies. Ageing Research Reviews, 85, 101840. https://doi.org/10.1016/j.arr.2022.101840
Vancouver
Ahmad MH, Rizvi MA, Ali M, Mondal AC. Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies. Ageing Research Reviews. 2023;85:101840. doi:10.1016/j.arr.2022.101840
BibTeX
@article{Ahmad2023,
author = {Ahmad, Mir Hilal and Rizvi, Moshahid Alam and Ali, Mansoor and Mondal, Amal Chandra},
title = {Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies},
journal = {Ageing Research Reviews},
year = {2023},
volume = {85},
pages = {101840},
doi = {10.1016/j.arr.2022.101840}
}
EUVIMED